Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis | Infection and Immunity

DOI: 10.1128/IAI.00595-18

Article Information

DOI

https://doi.org/10.1128/IAI.00595-18

PubMed

Published By

American Society for Microbiology Journals

History

Received July 30, 2018
Returned for modification August 14, 2018
Accepted November 12, 2018
Published online January 24, 2019.

Copyright & Usage

Copyright © 2019 McHugh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

Editors and / or Reviewers

Andreas J. Bäumler, Editor, University of California, Davis

Article Versions

Accepted Manuscript version (November 19, 2018).
You are viewing the most recent version of this article.

Author Information

Rebecca E. McHugh^a,^b,
Nicky O’Boyle^a,
James P. R. Connolly^a,
Paul A. Hoskisson^b and
Andrew J. Roe^a

^aInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
^bStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom

Address correspondence to Andrew J. Roe, Andrew.Roe{at}glasgow.ac.uk.
Citation McHugh RE, O’Boyle N, Connolly JPR, Hoskisson PA, Roe AJ. 2019. Characterization of the mode of action of Aurodox, a type III secretion system inhibitor from Streptomyces goldiniensis. Infect Immun 87:e00595-18. https://doi.org/10.1128/IAI.00595-18.

Article usage

Article usage: November 2018 to May 2019

Rendering graph...

	Abstract	Full	Pdf
Nov 2018	321	0	75
Dec 2018	505	0	69
Jan 2019	283	242	127
Feb 2019	9	291	219
Mar 2019	5	106	35
Apr 2019	6	71	50
May 2019	3	53	20

Print

KEYWORDS

Related Articles

Cited By...